RediNews
ETFs Holding IMGN »    IMGN Historical Stock Prices »
IMGN News Video: Tue, Sep 12, 2017, 1:07 PM — Tuesday Sector Laggards: Electric Utilities, Biotechnology Stocks


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ImmunoGen is a clinical-stage biotechnology company focused on developing antibody-drug conjugate (ADC), therapies that improve the lives of people with cancer. An ADC with Co.'s proprietary technology comprises an antibody that binds to a target found on tumor cells and is conjugated to one of its potent anti-cancer agents as a payload to kill the tumor cell once the ADC has bound to its target. Co.'s proprietary portfolio includes mirvetuximab soravtansine, an ADC targeting folate-receptor alpha. Co.'s platform of ADCs, includes IMGN779, its CD33-targeting product candidate for acute myeloid leukemia. Self directed investors in ImmunoGen, Inc. will be interested in keeping up with all ImmunoGen, Inc. news they can find, both IMGN news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on IMGN. At RediNews, we simplify this task by presenting both IMGN news releases originating from ImmunoGen, Inc. itself, and IMGN news from a variety of media outlets. Visitors can browse this news online and through our IMGN RSS news feed.

IMGN News

IMGN News — Articles, Videos, & Press Releases

Immunogen Ovarian Cancer Drug Fails in Phase III, Stock Sinks
Monday, March 4, 2019, 10:38 PM — Zacks
Short Interest Moves 13.8% Lower For IMGN
Thursday, February 28, 2019, 11:39 AM — Market News Video
We Did The Math PXSG Can Go To $45
Thursday, February 28, 2019, 8:18 AM — ETF Channel
Noteworthy Wednesday Option Activity: IMGN, WATT, SGRY
Wednesday, February 27, 2019, 3:21 PM — Stock Options Channel
ImmunoGen (IMGN) Beats on Earnings & Sales in Q4, Shares Up
Monday, February 11, 2019, 8:29 AM — Zacks
Noteworthy Friday Option Activity: VICR, IMGN, TTD
Friday, February 8, 2019, 3:18 PM — Stock Options Channel
ImmunoGen (IMGN) Reports Q4 Loss, Tops Revenue Estimates
Friday, February 8, 2019, 6:45 AM — Zacks
Notable Tuesday Option Activity: MSFT, EGHT, IMGN
Tuesday, January 29, 2019, 3:17 PM — Stock Options Channel
The Math Shows XBI Can Go To $131
Tuesday, January 22, 2019, 7:55 AM — ETF Channel
Notable Friday Option Activity: IMGN, SPLK, VCRA
Friday, January 11, 2019, 3:17 PM — Stock Options Channel
First Week of February 15th Options Trading For ImmunoGen (IMGN)
Thursday, January 3, 2019, 11:08 AM — Stock Options Channel
ImmunoGen Becomes Oversold (IMGN)
Thursday, December 20, 2018, 12:11 PM — Dividend Channel
PXSG's Holdings Could Mean 36% Gain Potential
Thursday, December 13, 2018, 9:25 AM — ETF Channel
First Week of IMGN July 2019 Options Trading
Wednesday, November 21, 2018, 10:46 AM — Stock Options Channel
Pick Up This Bargain Even Cheaper Than Director Goldberg Did
Monday, November 12, 2018, 11:12 AM — Dividend Channel
Implied ESML Analyst Target Price: $31
Friday, November 9, 2018, 7:36 AM — ETF Channel
Interesting IMGN Put And Call Options For December 21st
Wednesday, October 24, 2018, 1:12 PM — Stock Options Channel
Oversold Conditions For ImmunoGen (IMGN)
Monday, October 22, 2018, 11:51 AM — Dividend Channel
Notable Tuesday Option Activity: DWDP, IP, IMGN
Tuesday, October 9, 2018, 3:55 PM — Stock Options Channel
Implied TUSA Analyst Target Price: $40
Friday, October 5, 2018, 7:47 AM — ETF Channel
IMGN Crosses Above Key Moving Average Level
Friday, September 28, 2018, 4:53 PM — Market News Video
IMGN Makes Bullish Cross Above Critical Moving Average
Tuesday, August 21, 2018, 11:41 AM — Market News Video
Look Under The Hood: FAD Has 10% Upside
Thursday, August 16, 2018, 9:02 AM — ETF Channel
First Week of September 21st Options Trading For ImmunoGen (IMGN)
Wednesday, July 25, 2018, 10:46 AM — Stock Options Channel
Interesting IMGN Put And Call Options For August 17th
Monday, July 2, 2018, 10:37 AM — Stock Options Channel
IMGN Crosses Above Average Analyst Target
Thursday, June 21, 2018, 8:03 AM — ETF Channel
Interesting IMGN Put And Call Options For January 2019
Tuesday, May 22, 2018, 11:00 AM — Stock Options Channel
ImmunoGen Reaches Analyst Target Price
Tuesday, May 15, 2018, 9:28 AM — ETF Channel
Short Interest In ImmunoGen Expands By 18%
Tuesday, May 8, 2018, 10:12 PM — Market News Video
Noteworthy Friday Option Activity: IMGN, HABT, STZ
Friday, April 27, 2018, 3:36 PM — Stock Options Channel
First Week of June 15th Options Trading For ImmunoGen (IMGN)
Wednesday, April 25, 2018, 11:48 AM — Stock Options Channel
Noteworthy Tuesday Option Activity: UNH, IMGN, MSFT
Tuesday, April 17, 2018, 3:19 PM — Stock Options Channel
IMGN Crosses Above Average Analyst Target
Thursday, April 5, 2018, 9:13 AM — ETF Channel
IMGN is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

RMD News
WAT News
IRWD News
ARIA News
HCA News
ARAY News
CELG News
BSX News
CRL News
MOH News

RSS news feeds from RediNews are an ideal complement to other financial content on your market-focused website like stock quotes and charts. our news gives your users what they want — to see what is being published about the stocks they own, and what the companies themselves are publishing. Simply navigate to any RediNews news page by specific ticker symbol, then click the RSS icon for any news page to reach the associated RSS feed (the icon will look like this): . These feeds are made available to you free if charge. We also offer news by broad sector, and a feed of all recent stock news.

IMGN News | www.RediNews.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.